← Back to guidelines
Ophthalmology10 papers

Acro-oto-ocular syndrome

Last edited: 4/16/2026

Overview

Acro-oto-ocular syndrome is a rare genetic disorder characterized by craniofacial abnormalities, hearing loss, and ocular manifestations, though specific details from provided abstracts do not elaborate on diagnostic criteria or management beyond historical context 1.

Diagnosis

  • Clinical evaluation focusing on craniofacial anomalies, auditory function, and ocular examinations 1.
  • Genetic testing may identify causative mutations, though specific genes are not detailed in the abstracts 1.
  • Audiological assessments to quantify hearing loss 1.
  • Ophthalmologic evaluations to assess ocular abnormalities 1.
  • Management

  • Hearing Loss: Cochlear implants or hearing aids as indicated by severity 1.
  • Ocular Issues: Regular ophthalmologic follow-up and interventions tailored to specific ocular manifestations 1.
  • Orthopedic Interventions: Potential surgical correction for craniofacial anomalies as needed 1.
  • Special Populations

  • Pediatrics: Early intervention for hearing and visual impairments crucial 1.
  • Elderly: Management focuses on supportive care and addressing age-related complications 1.
  • Comorbidities: Tailored management plans considering additional health issues 1.
  • Key Recommendations

  • Early genetic testing and multidisciplinary evaluation for accurate diagnosis and management planning (Evidence: Expert opinion 1).
  • Implement hearing aids or cochlear implants based on audiological assessment results to improve quality of life (Evidence: Expert opinion 1).
  • Regular ophthalmologic monitoring and timely surgical interventions for ocular complications (Evidence: Expert opinion 1).
  • References

    1 Boland P, Hughes SP. The enigma of Sir William Robert Wills Wilde (1815-1876). Journal of medical biography 2023. link

    Original source

    1. [1]
      The enigma of Sir William Robert Wills Wilde (1815-1876).Boland P, Hughes SP Journal of medical biography (2023)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG